References
- Raskind W. H., Tirumali N., Jacobson R., Singer J., Fialkow P. J. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 1984; 63: 1318–1323
- Jacobs A., Clark R. E. Pathogenesis and clinical variations in the myelodysplastic syndromes. Clinics in Haematology, J. D. Griffin. W. B. Saunders Company, London, Philadelphia, Toronto 1986; 925–951
- Stollmann B., Fonatsch C., Havers W. Persistent Epstein-Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders. Br. J. Haematol. 1985; 60: 183–196
- Fonatsch C., Schaadt M, Kirchner H., Diehl V. A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines. Int. J. Cancer 1980; 26: 749–756
- ISCN. An International System for Human Cytogenic Nomenclature. Birth Defects: Original Article Series No.1, Vol. 21. National Foundation, March of Dimes, New York 1985
- Hsu T. C. Genetic predisposition to cancer with special reference to mutagen sensitivity. In. Vitro Cellular & Developmental Biology 1987; 23: 591–601
- Knuutila S., Simell O., Lipponen P., Saarinen I. Bone-marrow chromosomes in healthy subjects. Hereditas 1976; 82: 29–36
- Trent J. M., Kaneko Y., Mitelman F. Report of the committee on structural chromosome changes in neoplasia; Human Gene Mapping 1989; 10, Tenth International Workshop on Human Gene Mapping. Cytogenet. Cell Genet.; 51:533-562
- Cancer Cytogenetics, S. Heim, F. Mitelman. Alan R. Liss, Inc., New York 1989
- Fonatsch C., Haase D., Freund M., Bartels H., Tesch H. Partial trisomy 1q—A nonrandom primary chromosomal abnormality in myelodysplastic syndromes?. Cancer Genet. Cytogenet. 1992; 56: 243–253
- Fonatsch C., Gradl G., Rademacher J. Genetics of Hodgkin's Lymphoma. Recent Results in Cancer Res. 1989; 117: 35–49
- Geraedts J. P. M., Weber R. F. A., Kerkhofs H., Leeksma C. H. W. The preleukemic syndrome. Acta Med. Scand. 1980; 207: 447–454
- Knuutila S., Teerenhovi L., BorgstrÖM G. H. Chromosome instability is associated with hypodiploid clones in myelodysplastic syndromes. Hereditas 1984; 101: 19–30
- De Planque M. M., Kluin-Nelemans H. C., Van Krieken H. J. M., Kluin P. M., Brand A., Beverstock G. C., Willemze R., Van Rood J. J. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Brit. J. Haematol 1988; 70: 55–62
- Swolin B., RÖDjer S., Westin J. Bone marrow in vitro growth and cytogenic studies in patients with FAB-classified primary myelodysplastic syndromes. Am. J. Hematol. 1990; 34: 175–180
- McConnell T. S., Duncan M. H., Foucar K. The Southwestern Oncology Group Leukemia Cytogenetics Subcommittee Do random (non-clonal) chromosome abnormalities in bone marrow predict a clone to come?. Cancer Genet. Cytogenet. 1991; 53: 257–263